Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05058677 · ClinicalTrials.gov registry record · Phase 4
Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT05058677 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 10 participants.
The verdict
NCT05058677, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of nebulized lidocaine before Endotracheal suctioning (ETS) compared to instilled lidocaine and the effectiveness of aerosolized lidocaine versus instilled normal saline before ETS in attenuating the increase of intracranial pressure (ICP) in severe head injured children and to evaluate the feasibility of a trial involving instilled lidocaine and aerosolized lidocaine for the management of ETS and to evaluate the safety of nebulized lidocaine in traumatic brain injury (TBI) compared to instilled lidocaine and instilled sodium chloride (NS).
Interventions
- DRUG aerosolized 2% lidocaine (20mg/ml)
- DRUG instilled 0.9% sodium chloride (NS)
- DRUG instilled 2% lidocaine solution
- PROCEDURE Endotracheal Suctioning (ETS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2025-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05058677
The ClinicalTrials.gov registry entry for NCT05058677 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which aerosolized 2% lidocaine (20mg/ml) is the first listed.
NCT05058677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05058677 about?
NCT05058677 is a clinical study titled "Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury". The purpose of this study is to evaluate the effectiveness of nebulized lidocaine before Endotracheal suctioning (ETS) compared to instilled lidocaine and the effectiveness of aerosolized lidocaine versus instilled normal saline before ETS in attenuating the increase of intracranial pressure (ICP) i...
What is the current status of trial NCT05058677?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2021-11-09. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT05058677?
The interventions under investigation include: aerosolized 2% lidocaine (20mg/ml) (DRUG), instilled 0.9% sodium chloride (NS) (DRUG), instilled 2% lidocaine solution (DRUG), Endotracheal Suctioning (ETS) (PROCEDURE).
Who is sponsoring clinical trial NCT05058677?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.